India  

Covid-19: Govt may get Oxford shots in Jan-Feb, at 50% of MRP

IndiaTimes Sunday, 22 November 2020 ()
India is likely to get the first lot of anti-Covid shots in late January-early February. This will be possible as India plans to give Serum Institute of India emergency use approval for the Oxford-AstraZeneca vaccine candidate soon after it gets similar approval in the UK. The government, which will make bulk purchases, has also negotiated a better price — almost half that of the likely MRP of Rs 500-600 for the two-shot vaccine.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Government Government System or group of people governing an organized community, often a state

25% of PM-Kisan beneficiaries are women: Govt data

Nearly one-fourth of beneficiaries under the PM Kisan scheme, launched last year and which was utilised during the lockdown to offer relief to agriculturists,..
IndiaTimes
Foreign Office minister Baroness Sugg resigns over foreign aid cuts [Video]

Foreign Office minister Baroness Sugg resigns over foreign aid cuts

A Foreign Office minister has resigned in protest against the Government’sdecision to cut the overseas aid budget, saying such a move is “fundamentallywrong”.

Credit: PA - Press Association STUDIO    Duration: 00:49Published

Govt approves joint military logistics nodes in run-up to theatre commands

The government has now formally approved the first set of joint structures to handle logistics in the 15-lakh strong armed forces, in a step towards injecting..
IndiaTimes
Coronavirus pandemic in Sweden: Govt bans public gatherings of more than 8 people [Video]

Coronavirus pandemic in Sweden: Govt bans public gatherings of more than 8 people

Credit: FRANCE 24 English    Duration: 03:36Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

India to enhance bilateral ties with Seychelles in post-Covid era: Jaishankar

India has vowed to further enhance its strategic partnership with Seychelles in the post-COVID era as External Affairs Minister S Jaishankar held high-level..
IndiaTimes

Covid-19 caseload in India climbs to 93,92,919

India's Covid-19 caseload inched closer to the 94-lakh mark, while the number of people who have recuperated from the disease crossed 88 lakh pushing the..
IndiaTimes

Uttarakhand travel guidelines: COVID-19 test mandatory for people coming from Delhi

The Uttarakhand Police on Saturday announced that they would monitor details of the movement of people from other states to Uttarakhand.
DNA
Delhi Half Marathon flagged off at JLN Stadium amid poor air quality [Video]

Delhi Half Marathon flagged off at JLN Stadium amid poor air quality

The 16th edition of Airtel Delhi Half Marathon was flagged off at the Jawaharlal Nehru Stadium on November 29. Union Minister for Youth Affairs and Sports, Kiren Rijiju, flagged off the half marathon. ADHM followed the safety standards, with bio-secure zones to mitigate the spread of COVID-19. Air Quality Index (AQI) around the stadium was recorded at 249 (in poor category) as per Central Pollution Control Board (CPCB). India Meteorological Department (IMD) forecasts a minimum of 9 degrees C and maximum of 26 degrees C in Delhi for today.

Credit: ANI    Duration: 01:38Published

Maximum retail price


Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

‘PM Modi extremely knowledgeable on vaccine’: SII CEO Adar Poonawalla [Video]

‘PM Modi extremely knowledgeable on vaccine’: SII CEO Adar Poonawalla

Serum Institute India CEO Adar Poonawalla spoke on Prime Minister Narendra Modi’s visit to vaccine lab in Pune. Poonawalla said that he was amazed by the Prime Minister's knowledge about vaccines and vaccine production. He added that there were detailed discussions about the Covid-19 vaccine during his visit. Poonawalla said they are in the process of applying for emergency-use authorisation of the COVID-19 vaccine candidate in the next two weeks. "Implementation can only happen after the emergency-use licence is obtained. The licence will be granted based on the data submitted by us. We are in the process of submitting the data to the Drug Controller of India," he said. Watch the full video for more details.

Credit: HT Digital Content    Duration: 04:05Published

Centre may purchase 300-400 mn vaccine doses by July 2021, says SII's Poonawalla after PM Modi's visit

Poonawalla also disclosed that the SII will apply for emergency authorisation of the COVID-19 vaccine 'Covishield' in the next two weeks.
DNA

PM Modi visits vaccine plants in 3 cities, reviews progress

Prime Minister Narendra Modi on Saturday visited the units of three vaccine manufacturers in India to review the progress of vaccine development and..
IndiaTimes
COVID-19 vaccine will be distributed initially in India: CEO Serum Institute of India [Video]

COVID-19 vaccine will be distributed initially in India: CEO Serum Institute of India

COVID-19 vaccine will be distributed initially in India, informed Chief executive officer (CEO) of Serum Institute of India, Adar Poonawalla on November 28. He said, "Vaccine will be distributed initially in India, then we will look at the COVAX countries which are mainly in Africa. The UK and European markets are being taken care of by AstraZeneca and Oxford. Our priority is India and COVAX countries." Earlier in the day, Prime Minister Narendra Modi visited Serum Institute of India in Pune, Maharashtra to and reviewed COVID-19 vaccine development.

Credit: ANI    Duration: 01:25Published

AstraZeneca British-Swedish pharmaceutical company

Gujarat: PM Modi reviews vaccine development at Zydus Cadila facility

Prime Minister Narendra Modi on Saturday began his three-city visit to review coronavirus vaccine development work by going to pharma major Zydus Cadila's..
IndiaTimes

Vaccine tour: PM Modi arrives at SII in Pune to review COVID-19 vaccine development

The Serum Institute of India has partnered with global pharma giant AstraZeneca and Oxford University for the vaccine.
DNA
Wall Street too giddy over vaccines: economist [Video]

Wall Street too giddy over vaccines: economist

Spartan Capital Securities chief market economist Peter Cardillo tells Reuters Fred Katayama investors are overly optimistic on the impact of vaccines as AstraZeneca's trial data comes under question. He also provides his view on retailers' prospects for the holiday shopping season.

Credit: Reuters Studio    Duration: 05:13Published

Related news from verified sources

UK secures 2 m more doses of Moderna's Covid vaccine

Britain has secured two million doses of Moderna Inc's Covid-19 vaccine candidate, to be available in Europe as early as the spring, the government said on...
IndiaTimes Also reported by •Mid-DayDNA

'Frontline workers will be first to get COVID-19 vaccine', PM Narendra Modi tells CMs

Prime Minister Narendra Modi on Tuesday said that health and frontline workers will get priority when it comes to getting the Covid vaccine when it arrives,...
Mid-Day Also reported by •DNAHindu

Narendra Modi to visit 3 vaccine centres in Ahmedabad, Pune and Hyderabad on Nov 28

Prime Minister Narendra Modi will embark on a three-city visit on Saturday to personally review Covid vaccine development and manufacturing process. Accordingly,...
Mid-Day Also reported by •DNA